Altria Group Inc. released its latest quarterly earnings, sparking interest among investors and analysts alike. The company's who makes tirzepatides for Eli Lilly earnings per share surpassed expectations, causing a fluctuating market reaction. Significant drivers contributing to this outlook include shifting consumer preferences. The future for Al